Translation of next-generation sequencing (NGS) into molecular diagnostics

LaboratoriumsMedizin

Volumn 34, Issue 6, 2010, Pages 311-318

  Kotschote, Stefan ^a   Wagner, Carola ^a   Marschall, Christoph ^b   Mayer, Karin ^b   Hirv, Kaimo ^b   Kerick, Martin ^c   Timmermann, Bernd ^c   Klein, Hanns Georg ^a,b  

^a IMGM LABORATORIES GMBH   (Germany)

^b Laboratory Medicine Dr Klein and Dr Rost   (Germany)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

immunogenetics; molecular diagnostics; molecular genetics; next generation sequencing (NGS); target enrichment

Indexed keywords

GENOMIC DNA;

COMMERCIAL PHENOMENA; COST; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; GENOMICS; HISTOCOMPATIBILITY TEST; HUMAN; HYBRIDIZATION; IMMUNOGENETICS; MOLECULAR GENETICS; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; REVIEW; SAMPLE; TIME; TRANSCRIPTOMICS; VALIDATION PROCESS;

EID: 78249266368     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2010.054     Document Type: Review

References (41)

1. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437:376-80.
2. Erratum in: Nature 2006;441:120.
3. Stangier KA. Neue Sequenziertechnologien: ein kurzer Vergleich/Next- generation sequencing: a short comparison. J Lab Med 2009;33:267-70.
4. Cullen P, Hoffmann G, Klein H-G, Funke H. Next-generation sequencing und hochparallele Genexpressionsanalyse in der klinischen Diagnostik. J Lab Med 2010;34:349-356.
5. Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009;55:641-58.
6. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010;11:31-46.
7. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007;79:7576-9.
8. Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007;104:13116-21.
9. Dennis Lo YM, Chiu RW. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-7.
10. Korshunova Y, Maloney RK, Lakey N, Citek RW, Bacher B, Budiman A, et al. Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res 2008;18:19-29.
11. Meyer M, Stenzel U, Myles S, Prüfer K, Hofreiter M. Targeted high-throughput sequencing of tagged nucleic acid samples. Nucleic Acids Res 2007;35: e97.
12. Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 2009;27:1025-31.
13. ™ system. http://www.fluidigm.com/applications/access.html.
14. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, Song X, et al. Direct selection of human genomic loci by microarray hybridization. Nat Methods 2007;4:903-5.
15. Okou DT, Steinberg KM, Middle C, Cutler DJ, Albert TJ, Zwick ME. Microarray-based genomic selection for highthroughput resequencing. Nat Methods 2007;4:907-9.
16. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, Smith SW, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007;39:1522-7.
17. Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-9.
18. Tewhey R, Nakano M, Wang X, Pabón-Peña C, Novak B, Giuffre A, et al. Enrichment of sequencing targets from the human genome by solution hybridization. Genome Biol 2009;10: R116.
19. Craig DW, Pearson JV, Szelinger S, Sekar A, Redman M, Corneveaux JJ, et al. Identification of genetic variants using barcoded multiplexed sequencing. Nat Methods 2008;5:887-93.
20. Garber K. Fixing the front end. Nat Biotechnol 2008;26:1101-4.
21. Lee H, O'Connor BD, Merriman B, Funari VA, Homer N, Chen Z, et al. Improving the efficiency of genomic loci capture using oligonucleotide arrays for high throughput resequencing. BMC Genomics 2009;10:646.
22. Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 2009;10: R32.
23. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010;362:1181-91.
24. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-5.
25. Goossens D, Moens LN, Nelis E, Lenaerts AS, Glassee W, Kalbe A, et al. Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat 2009;30:472-6.
26. Hoischen A, Gilissen C, Arts P, Wieskamp N, van der Vliet W, Vermeer S, et al. Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat 2010;31:494-9.
27. Chou LS, Liu CS, Boese B, Zhang X, Mao R. DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model. Clin Chem 2010;56:62-72.
28. Raca G, Jackson C, Warman B, Bair T, Schimmenti LA. Next generation sequencing in research and diagnostics of ocular birth defects. Mol Genet Metab 2010;100:184-92.
29. Callewaert B, Malfait F, Loeys B, De Paepe A. Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 2008;22:165-89.
30. von Kodolitsch Y, Rybczynski M, Bernhardt A, Mir TS, Treede H, Dodge-Khatami, et al. Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions? Vasa 2010;39:17-32.
31. Ottman R, Hirose S, Jain S, Lerche H, Lopes-Cendes I, Noebels JL, et al. Genetic testing in the epilepsies - report of the ILAE Genetics Commission. Epilepsia 2010;51:655-70.
32. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
33. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007;110:4576-83.
34. European Federation for Immunogenetics. Standards for Histocompatibility Testing. http://www.efiweb.eu/fileadmin/user-upload/pdf/Accreditation/version-5- 6-1-Revision-Nomenclature.pdf. Accessed October 18, 2010.
35. Hirv K, Bloch K, Fischer M, Einsiedler B, Schrezenmeier H, Mytilineos J. Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone Marrow Transplant 2009;44:433-40.
36. Hansen JA. Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality. Biol Blood Marrow Transplant 2009;15(Suppl 1): e1-7.
37. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med 2007;4: e8.
38. Kawase T, Matsuo K, Kashiwase K, Inoko H, Saji H, Ogawa S, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009;113:2851-8.
39. Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, et al. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009;74:393-403.
40. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004;64:631-49.
41. Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens 2009;73:1-8.